Case report reveals complete resolution of leukemia cutis and acrodermatitis chronica atrophicans, suggesting doxycycline's potential role in lymphoma therapy.
Key Points
Complete clearance of leukemia cutis was achieved after doxycycline treatment in a patient with CLL.
The patient had a chronic Borrelia burgdorferi infection, confirmed by PCR analysis and serology.
Clinical resolution of skin lesions occurred without initiation of CLL-specific therapy during follow-up.
Doxycycline may represent a novel therapeutic approach for managing skin manifestations related to CLL.